Coronavirus disease 2019 (Covid-19) disproportionately results in hospitalization or death in older patients and those with underlying conditions. Sotrovimab is a pan-sarbecovirus monoclonal antibody that was designed to prevent progression of Covid-19 in high-risk patients early in the course of disease.

Matéria original


Incluir para juntos reimaginar


Successful treatment of severe COVID-19 pneumonia with tocilizumab: A series of three cases